Timber Pharmaceuticals, Inc. (TMBR)
Stock Price:
$1.87 USD
0.00 (0.00%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
22.19M |
| Revenue (ttm) |
351,553 |
| Net Income (ttm) |
-8.08M |
| Shares Out |
11.85M |
| EPS (ttm) |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 6, 2020 |
| Last Price |
$1.87 |
| Previous Close |
$1.87 |
| Change ($) |
0.00 |
| Change (%) |
0.00% |
| Day's Open |
1.88 |
| Day's Range |
1.85 - 1.88 |
| Day's Volume |
159,787 |
| 52-Week Range |
1.75 - 12.60 |
More Stats
| Market Cap |
22.19M |
| Enterprise Value |
23.80M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
11.85M |
| Float |
3.81M |
| EPS (basic) |
n/a |
| EPS (diluted) |
n/a |
| FCF / Share |
-5.19 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
391,365 |
| Short Ratio |
0.49 |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
63.13 |
| PB Ratio |
n/a |
| Revenue |
351,553 |
| Operating Income |
-7.66M |
| Net Income |
-8.08M |
| Free Cash Flow |
-7.80M |
| Net Cash |
-1.61M |
| Net Cash / Share |
-0.14 |
| Gross Margin |
-869.86% |
| Operating Margin |
-2,179.19% |
| Profit Margin |
n/a |
| FCF Margin |
-2,219.01% |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
-1,121.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
12.0
Current: $1.87
High
12.0
Target: 12.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | - | 0.06 | 0.07 | 0.10 | 0.06 | - |
| Revenue Growth | - | -21.92% | -27% | 56.25% | - | - |
| Gross Profit | - | -0.03 | -0.18 | -0.42 | -0.17 | - |
| Operating Income | -9.69 | -16.51 | -16.88 | -18.43 | -15.16 | -7.77 |
| Net Income | -9.69 | -17.26 | -16.64 | -18.41 | -15.60 | -7.81 |
| Shares Outstanding | 1.08 | 0.64 | 0.29 | 0.12 | 0.06 | 0.03 |
| Earnings Per Share | -9.00 | -26.76 | -57.00 | -156.01 | -267.01 | -240.01 |
| Operating Cash Flow | -10.11 | -14.99 | -15.59 | -15.75 | -12.61 | -6.00 |
| Capital Expenditures | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 | -0.23 |
| Free Cash Flow | -10.14 | -15.04 | -15.63 | -15.79 | -12.65 | -6.23 |
| Cash & Equivalents | 0.73 | 3.07 | 7.58 | 6.50 | 4.04 | 0.00 |
| Total Debt | 0.94 | - | - | - | - | - |
| Net Cash / Debt | -0.21 | 3.07 | 7.58 | 6.50 | 4.04 | 0.00 |
| Assets | 2.13 | 3.65 | 8.09 | 7.10 | 4.85 | - |
| Liabilities | 2.47 | 2.36 | 3.02 | 4.13 | 2.80 | - |
| Book Value | -0.34 | 1.30 | 5.07 | 2.97 | 2.05 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Timber Pharmaceuticals, Inc. |
| Country |
United States |
| Employees |
3 |
| CEO |
John Koconis |
Stock Information
| Ticker Symbol |
TMBR |
| Stock Exchange |
NYSE American |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
NYSEAMERICAN: TMBR |
Description
Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.